Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder

OBJECTIVE: To assess possible adverse effects on breastfed infants of mothers receiving monoclonal antibodies (MAbs) during pregnancy and/or lactation. METHODS: We identified 23 patients from the German Multiple Sclerosis and Pregnancy Registry (DMSKW) who received MAbs (17 natalizumab and 6 anti-CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciplea, Andrea Ines, Langer-Gould, Annette, de Vries, Annick, Schaap, Tiny, Thiel, Sandra, Ringelstein, Marius, Gold, Ralf, Hellwig, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188475/
https://www.ncbi.nlm.nih.gov/pubmed/32327455
http://dx.doi.org/10.1212/NXI.0000000000000723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188475/
https://www.ncbi.nlm.nih.gov/pubmed/32327455
http://dx.doi.org/10.1212/NXI.0000000000000723

Ejemplares similares